08037 CH BIOTECH SER
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.33X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 16.4% | Net Margin | N/A |
Total Debt/Equity | 70.9% | Return on Equity | N/A |
Price/Book | 3.76X | Return on Assets | N/A |
(HKD 1.020) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -198.15 | -95.45 | 258.09 | 19.39 | 30.17 |
---|---|---|---|---|---|
Net Profit Growth (%) | -107.6 | -137.0 | +1,231.4 | -35.8 | +130.5 |
Earnings Per Share (HKD) | -0.205 | -0.099 | 0.268 | 0.02 | 0.031 |
Earnings Per Share Growth (%) | -106.5 | -137.0 | +1,232.8 | -35.6 | +130.3 |
Dividend Per Share (HKD) | No dividend | No dividend | 0.010 | No dividend | No dividend |
P/E* (X) | N/A | N/A | 3.81 | 50.75 | 32.69 |
Yield (%) | N/A | N/A | 0.98 | N/A | N/A |
Dividend Share (%) | N/A | N/A | 3.73 | N/A | N/A |
Book NAV (HKD) | 0.272 | 0.480 | 0.626 | 0.411 | 0.355 |
Auditors' Opinion | Qualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 38.872 | 32.449 | +19.8 | 182.357 |
Operating Result | -37.159 | -126.149 | -70.5 | -21.906 |
Associates | 0 | 0 | N/A | -2.771 |
Profit Before Taxation | -37.159 | -126.258 | -70.6 | -24.677 |
Taxation | -0.406 | -0.527 | -23.0 | 3.044 |
Profit /( Loss) After Taxation | -36.753 | -125.731 | -70.8 | -27.721 |
Minority Interests | -4.747 | -45.814 | -89.6 | 2.763 |
Net Profit | -32.006 | -79.917 | -60.0 | -30.484 |
Earnings Per Share () | -0.0328 | -0.0830 | -60.5 | -0.0316 |
Announcement Date | 2025-08-27 | 2024-08-26 | NA | 2023-08-11 |
* Annualised
Last Update Time: 2025-09-08 21:40:25